condition found
Source: |
Type: |
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”. Chemo-Sensitizers: -Curcumin -Resveratrol -EGCG -Quercetin -Genistein -Berberine -Piperine: alkaloid from black pepper -Ginsenosides: active components of ginseng -Silymarin -Allicin -Lycopene -Ellagic acid -caffeic acid phenethyl ester -flavopiridol -oleandrin -ursolic acid -butein -betulinic acid |
2325- | 2DG,  |   | Research Progress of Warburg Effect in Hepatocellular Carcinoma |
- | Review, | Var, | NA |
2424- | 2DG,  | SRF,  |   | The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells |
- | in-vitro, | HCC, | Hep3B | - | in-vitro, | HCC, | HUH7 |
2423- | 2DG,  | SRF,  |   | 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells |
- | in-vitro, | HCC, | NA |
1339- | 2DG,  | Cisplatin,  |   | 2-Deoxy-d-Glucose Combined with Cisplatin Enhances Cytotoxicity via Metabolic Oxidative Stress in Human Head and Neck Cancer Cells |
- | in-vitro, | HNSCC, | FaDu |
1337- | 2DG,  | Rad,  |   | 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer |
- | in-vivo, | NA, | NA |
2646- | AL,  |   | Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress |
- | in-vitro, | Pca, | DU145 | - | in-vitro, | Melanoma, | RPMI-8226 |
2647- | AL,  |   | The Mechanism in Gastric Cancer Chemoprevention by Allicin |
- | Review, | GC, | NA |
2667- | AL,  |   | Allicin in Digestive System Cancer: From Biological Effects to Clinical Treatment |
- | Review, | GC, | NA |
2663- | AL,  |   | Therapeutic Effect of Allicin on Glioblastoma |
- | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG |
278- | ALA,  |   | The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment |
- | Review, | NA, | NA |
- | in-vitro, | BC, | MCF-7 |
3434- | ALA,  |   | Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
3541- | ALA,  |   | Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology |
- | Review, | Var, | NA |
1440- | AMQ,  |   | Lysosomotropism depends on glucose: a chloroquine resistance mechanism |
- | in-vitro, | BC, | 4T1 |
1009- | And,  | 5-FU,  |   | Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer |
- | in-vivo, | CRC, | HCT116 | - | in-vitro, | CRC, | SW480 |
1350- | And,  | Cisplatin,  |   | Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer |
- | in-vitro, | Colon, | NA |
1353- | And,  |   | Andrographolide Induces Apoptosis and Cell Cycle Arrest through Inhibition of Aberrant Hedgehog Signaling Pathway in Colon Cancer Cells |
- | in-vitro, | Colon, | HCT116 |
581- | Api,  | Cisplatin,  |   | The natural flavonoid apigenin sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy |
- | in-vitro, | Pca, | CD44+ |
2584- | Api,  | Chemo,  |   | The versatility of apigenin: Especially as a chemopreventive agent for cancer |
- | Review, | Var, | NA |
2586- | Api,  | doxoR,  |   | Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway |
- | in-vitro, | HCC, | Bel-7402 |
2594- | Api,  | docx,  |   | Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells |
- | in-vitro, | Lung, | A549 |
2640- | Api,  |   | Apigenin: A Promising Molecule for Cancer Prevention |
- | Review, | Var, | NA |
2639- | Api,  |   | Plant flavone apigenin: An emerging anticancer agent |
- | Review, | Var, | NA |
2636- | Api,  |   | Apigenin unveiled: an encyclopedic review of its preclinical and clinical insights |
- | Review, | NA, | NA |
1999- | Api,  | doxoR,  |   | Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation |
- | in-vitro, | Nor, | NRK52E | - | in-vitro, | Nor, | MPC5 | - | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
1537- | Api,  |   | Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer |
- | Review, | PC, | NA |
1549- | Api,  | Chemo,  |   | Chemoprotective and chemosensitizing effects of apigenin on cancer therapy |
- | Review, | NA, | NA |
1076- | ART/DHA,  |   | The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer |
- | Review, | NA, | NA |
571- | ART/DHA,  | TMZ,  |   | Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence |
- | vitro+vivo, | GBM, | A172 | - | vitro+vivo, | GBM, | U87MG |
564- | ART/DHA,  | Cisplatin,  |   | Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling |
- | in-vitro, | NA, | HN30 |
2577- | ART/DHA,  |   | Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives |
- | Review, | Var, | NA |
2575- | ART/DHA,  | docx,  |   | Artemisia santolinifolia-Mediated Chemosensitization via Activation of Distinct Cell Death Modes and Suppression of STAT3/Survivin-Signaling Pathways in NSCLC |
- | in-vitro, | Lung, | H23 |
2572- | ART/DHA,  | SRF,  |   | Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax |
- | in-vitro, | AML, | NA |
2571- | ART/DHA,  |   | Cancer combination therapies with artemisinin-type drugs |
- | Review, | Var, | NA |
3382- | ART/DHA,  |   | Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge? |
- | Review, | Var, | NA |
3396- | ART/DHA,  |   | Progress on the study of the anticancer effects of artesunate |
- | Review, | Var, | NA |
1334- | AS,  |   | Astragalus membranaceus: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer |
- | Review, | NA, | NA |
1363- | Ash,  | doxoR,  |   | Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer |
- | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | CaOV3 | - | in-vivo, | NA, | NA |
1362- | Ash,  | GEM,  |   | Synergistic Inhibition of Pancreatic Cancer Cell Growth and Migration by Gemcitabine and Withaferin A |
- | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | Hs766t |
1358- | Ash,  |   | Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms |
- | Review, | Var, | NA |
1368- | Ash,  | Cisplatin,  |   | Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’ |
- | in-vitro, | Colon, | HT-29 | - | in-vitro, | BC, | MDA-MB-231 |
- | in-vivo, | BC, | 4T1 |
2295- | Ba,  | 5-FU,  |   | Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway |
- | in-vitro, | GC, | AGS |
2298- | Ba,  |   | Flavonoids Targeting HIF-1: Implications on Cancer Metabolism |
- | Review, | Var, | NA |
2597- | Ba,  |   | Baicalein – An Intriguing Therapeutic Phytochemical in Pancreatic Cancer |
- | Review, | PC, | NA |
2605- | Ba,  | BA,  |   | Potential therapeutic effects of baicalin and baicalein |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2606- | Ba,  |   | Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma |
- | Review, | HCC, | NA |
2608- | Ba,  |   | Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity |
- | in-vitro, | HCC, | Bel-7402 |
2615- | Ba,  |   | The Multifaceted Role of Baicalein in Cancer Management through Modulation of Cell Signalling Pathways |
- | Review, | Var, | NA |
1393- | BBR,  | EPI,  |   | Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest |
- | in-vitro, | Bladder, | T24 |
1385- | BBR,  | 5-FU,  |   | Low-Dose Berberine Attenuates the Anti-Breast Cancer Activity of Chemotherapeutic Agents via Induction of Autophagy and Antioxidation |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
1389- | BBR,  | Lap,  |   | Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS |
- | in-vitro, | BC, | BT474 | - | in-vitro, | BC, | AU-565 |
2674- | BBR,  |   | Berberine: A novel therapeutic strategy for cancer |
- | Review, | Var, | NA | - | Review, | IBD, | NA |
2686- | BBR,  |   | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Nor, | NA |
2752- | BetA,  |   | Betulinic acid: a natural product with anticancer activity |
- | Review, | Var, | NA |
2750- | BetA,  | GEM,  |   | Betulinic acid, a major therapeutic triterpene of Celastrus orbiculatus Thunb., acts as a chemosensitizer of gemcitabine by promoting Chk1 degradation |
- | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | Lung, | H1299 |
2747- | BetA,  |   | Betulinic acid, a natural compound with potent anticancer effects |
- | Review, | Var, | NA |
2759- | BetA,  |   | Chemopreventive and Chemotherapeutic Potential of Betulin and Betulinic Acid: Mechanistic Insights From In Vitro, In Vivo and Clinical Studies |
- | Review, | Var, | NA |
2763- | BetA,  |   | Betulinic Acid Inhibits the Stemness of Gastric Cancer Cells by Regulating the GRP78-TGF-β1 Signaling Pathway and Macrophage Polarization |
- | in-vitro, | GC, | NA |
2727- | BetA,  |   | Betulinic acid in the treatment of breast cancer: Application and mechanism progress |
- | Review, | BC, | NA |
2729- | BetA,  |   | Betulinic acid in the treatment of tumour diseases: Application and research progress |
- | Review, | Var, | NA |
2737- | BetA,  |   | Multiple molecular targets in breast cancer therapy by betulinic acid |
- | Review, | Var, | NA |
2735- | BetA,  |   | Betulinic acid as apoptosis activator: Molecular mechanisms, mathematical modeling and chemical modifications |
- | Review, | Var, | NA |
2732- | BetA,  | Chemo,  |   | Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78 |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
2731- | BetA,  |   | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
- | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
727- | Bor,  | RSL3,  | erastin,  |   | Enhancement of ferroptosis by boric acid and its potential use as chemosensitizer in anticancer chemotherapy |
- | in-vitro, | Liver, | HepG2 |
2767- | Bos,  |   | The potential role of boswellic acids in cancer prevention and treatment |
- | Review, | Var, | NA |
2776- | Bos,  |   | Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities |
- | Review, | Var, | NA |
2775- | Bos,  |   | The journey of boswellic acids from synthesis to pharmacological activities |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
2774- | Bos,  |   | Boswellia ovalifoliolata abrogates ROS mediated NF-κB activation, causes apoptosis and chemosensitization in Triple Negative Breast Cancer cells |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-453 |
1425- | Bos,  |   | Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2/HO-1 Defense Pathway |
- | in-vivo, | Nor, | NA |
- | in-vitro, | Pca, | DU145 |
1426- | Bos,  | CUR,  | Chemo,  |   | Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer |
- | in-vivo, | CRC, | NA | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | RKO | - | in-vitro, | CRC, | SW480 | - | in-vitro, | RCC, | SW-620 | - | in-vitro, | RCC, | HT-29 | - | in-vitro, | CRC, | Caco-2 |
1449- | Bos,  | Chemo,  |   | Anti-proliferative, Pro-apoptotic, and Chemosensitizing Potential of 3-Acetyl-11-keto-β-boswellic Acid (AKBA) Against Prostate Cancer Cells |
- | in-vitro, | Pca, | PC3 |
1101- | CA,  | Tras,  |   | Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells |
- | in-vitro, | BC, | NA |
1650- | CA,  |   | Adjuvant Properties of Caffeic Acid in Cancer Treatment |
- | Review, | Var, | NA |
1651- | CA,  | PBG,  |   | Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer |
- | Review, | Var, | NA |
2015- | CAP,  | CUR,  | urea,  |   | Anti-cancer Activity of Sustained Release Capsaicin Formulations |
- | Review, | Var, | NA |
2019- | CAP,  |   | Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer |
- | Review, | Var, | NA |
2795- | CHr,  |   | Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53 |
- | in-vitro, | Liver, | HepG2 |
2801- | CHr,  |   | AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells |
- | in-vitro, | Lung, | A549 |
2803- | CHr,  | 5-FU,  |   | Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells |
- | in-vitro, | GC, | AGS |
2780- | CHr,  |   | Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review |
- | Review, | Var, | NA |
2784- | CHr,  |   | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
- | Review, | Var, | NA |
2786- | CHr,  |   | Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives |
- | Review, | Var, | NA |
2788- | CHr,  |   | Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action |
- | Review, | Var, | NA |
2591- | CHr,  | doxoR,  |   | Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway |
- | in-vitro, | HCC, | Bel-7402 |
1587- | Citrate,  |   | ATP citrate lyase: A central metabolic enzyme in cancer |
- | Review, | NA, | NA |
1578- | Citrate,  |   | Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update |
- | Review, | Var, | NA |
1585- | Citrate,  |   | Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer |
- | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Nor, | HEK293 |
1593- | Citrate,  |   | Citrate Induces Apoptotic Cell Death: A Promising Way to Treat Gastric Carcinoma? |
- | in-vitro, | GC, | BGC-823 | - | in-vitro, | GC, | SGC-7901 |
1596- | Cu,  | CDT,  |   | Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review |
- | Review, | NA, | NA |
1572- | Cu,  |   | Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy |
- | Review, | NA, | NA |
1487- | CUR,  |   | Relationship and interactions of curcumin with radiation therapy |
- | Review, | Var, | NA |
1486- | CUR,  |   | Curcumin and lung cancer--a review |
- | Review, | Lung, | NA |
1485- | CUR,  | Chemo,  | Rad,  |   | Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs |
- | Review, | Var, | NA |
1411- | CUR,  | Cisplatin,  |   | Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects |
- | Review, | Var, | NA |
1488- | CUR,  |   | Anti-Cancer and Radio-Sensitizing Effects of Curcumin in Nasopharyngeal Carcinoma |
2308- | CUR,  |   | Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells |
- | in-vitro, | Liver, | HepG2 |
2688- | CUR,  |   | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Var, | NA | - | Review, | AD, | NA |
1848- | dietFMD,  | Chemo,  |   | Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial |
- | Trial, | BC, | NA |
1854- | dietFMD,  |   | How Far Are We from Prescribing Fasting as Anticancer Medicine? |
- | Review, | Var, | NA |
1849- | dietFMD,  |   | The emerging role of fasting-mimicking diets in cancer treatment |
- | Review, | Var, | NA |
1857- | dietFMD,  |   | Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy |
- | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
1847- | dietFMD,  | VitC,  |   | Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers |
- | in-vitro, | PC, | PANC1 |
1846- | dietFMD,  | VitC,  |   | A fasting-mimicking diet and vitamin C: turning anti-aging strategies against cancer |
- | Study, | Var, | NA |
1845- | dietFMD,  |   | Fasting and fasting mimicking diets in cancer prevention and therapy |
- | Review, | Var, | NA |
1861- | dietFMD,  | Chemo,  |   | Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models |
- | in-vitro, | Colon, | CT26 | - | in-vivo, | NA, | NA |
1863- | dietFMD,  | Chemo,  |   | Effect of fasting on cancer: A narrative review of scientific evidence |
- | Review, | Var, | NA |
1810- | dietKeto,  | Oxy,  |   | The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer |
- | in-vivo, | Var, | NA |
1893- | dietMet,  |   | Clinical Studies of Methionine-Restricted Diets for Cancer Patients |
- | Review, | Var, | NA |
1895- | dietMet,  |   | Altering Diet Enhances Response to Cancer Treatments in Mice |
- | Review, | Var, | NA |
1897- | dietMet,  |   | Methionine metabolism in health and cancer: a nexus of diet and precision medicine |
- | Review, | Var, | NA |
2264- | dietMet,  |   | Methionine restriction for cancer therapy: From preclinical studies to clinical trials |
- | Review, | Var, | NA |
2268- | dietMet,  |   | Methionine dependency and cancer treatment |
- | Review, | Var, | NA |
2263- | dietMet,  |   | Methionine Restriction and Cancer Biology |
- | Review, | Var, | NA |
1613- | EA,  |   | Ellagitannins in Cancer Chemoprevention and Therapy |
- | Review, | Var, | NA |
1618- | EA,  |   | A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action |
- | Review, | BC, | NA |
1621- | EA,  |   | The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art |
- | Review, | Var, | NA |
2309- | EGCG,  | Chemo,  |   | Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts |
- | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Nor, | HPNE | - | in-vitro, | PC, | PANC1 | - | in-vivo, | NA, | NA |
3201- | EGCG,  |   | Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential |
- | Review, | NA, | NA |
1322- | EMD,  |   | The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers |
- | Review, | Var, | NA |
1325- | EMD,  | PacT,  |   | Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo |
- | vitro+vivo, | Lung, | A549 |
2148- | Ex,  |   | Effects of Exercise on Cancer Treatment Efficacy: A Systematic Review of Preclinical and Clinical Studies |
- | Review, | Var, | NA |
2150- | Ex,  |   | Roles and molecular mechanisms of physical exercise in cancer prevention and treatment |
- | Review, | Var, | NA |
1654- | FA,  |   | Molecular mechanism of ferulic acid and its derivatives in tumor progression |
- | Review, | Var, | NA |
2845- | FIS,  |   | Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy |
- | Review, | Var, | NA |
2847- | FIS,  |   | Fisetin-induced cell death, apoptosis, and antimigratory effects in cholangiocarcinoma cells |
- | in-vitro, | CCA, | NA |
2852- | FIS,  |   | A comprehensive view on the fisetin impact on colorectal cancer in animal models: Focusing on cellular and molecular mechanisms |
- | Review, | CRC, | NA |
2854- | FIS,  |   | New Perspectives for Fisetin |
- | Review, | Var, | NA | - | Review, | Stroke, | NA |
2857- | FIS,  |   | A review on the chemotherapeutic potential of fisetin: In vitro evidences |
- | Review, | Var, | NA |
2825- | FIS,  |   | Exploring the molecular targets of dietary flavonoid fisetin in cancer |
- | Review, | Var, | NA |
2830- | FIS,  |   | Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent |
- | Review, | Var, | NA |
2831- | FIS,  |   | Fisetin as a chemoprotective and chemotherapeutic agent: mechanistic insights and future directions in cancer therapy |
- | Review, | Var, | NA |
2839- | FIS,  |   | Dietary flavonoid fisetin for cancer prevention and treatment |
- | Review, | Var, | NA |
2843- | FIS,  |   | Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential |
- | Review, | Var, | NA |
2426- | GamB,  |   | Anti-cancer natural products isolated from chinese medicinal herbs |
- | Review, | Var, | NA |
1965- | GamB,  | doxoR,  |   | Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis |
- | in-vitro, | Ovarian, | SKOV3 |
1966- | GamB,  | Cisplatin,  |   | Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | NCIH1299 |
805- | GAR,  | Cisplatin,  | PacT,  |   | Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells |
- | Review, | NA, | NA |
2521- | H2,  |   | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
- | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
2520- | H2,  |   | The Impact of Molecular Hydrogen on Mitochondrial ROS and Apoptosis in Colorectal Cancer Cells |
- | in-vitro, | CRC, | NA |
1627- | HCA,  |   | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance |
- | Review, | Var, | NA |
1638- | HCAs,  |   | Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications |
- | Review, | Nor, | NA |
1643- | HCAs,  |   | Mechanisms involved in the anticancer effects of sinapic acid |
- | Review, | Var, | NA |
2883- | HNK,  |   | Honokiol targets mitochondria to halt cancer progression and metastasis |
- | Review, | Var, | NA |
2885- | HNK,  |   | Honokiol: a novel natural agent for cancer prevention and therapy |
2895- | HNK,  |   | Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity |
- | in-vitro, | Lung, | PC9 |
2900- | HNK,  |   | The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance |
- | Review, | Var, | NA |
2864- | HNK,  |   | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
- | Review, | Var, | NA |
2865- | HNK,  |   | Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma |
- | in-vitro, | MB, | DAOY | - | vitro+vivo, | NA, | NA |
1060- | LT,  | BTZ,  |   | Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma |
- | vitro+vivo, | Melanoma, | NA |
2916- | LT,  |   | Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2919- | LT,  |   | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
- | Review, | Var, | NA |
2914- | LT,  |   | Therapeutic Potential of Luteolin on Cancer |
- | Review, | Var, | NA |
2589- | LT,  | Chemo,  |   | Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway |
- | in-vitro, | BC, | MDA-MB-231 |
2588- | LT,  | Chemo,  |   | Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway |
- | in-vitro, | CRC, | HCT116 |
2587- | LT,  |   | Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs |
- | in-vitro, | Lung, | A549 |
1715- | Lyco,  |   | Pro-oxidant Actions of Carotenoids in Triggering Apoptosis of Cancer Cells: A Review of Emerging Evidence |
- | Review, | Var, | NA |
1714- | Lyco,  |   | Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load |
- | in-vitro, | Ovarian, | OV-MZ-6 | - | in-vivo, | NA, | NA |
1708- | Lyco,  |   | The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies |
- | Review, | Var, | NA |
3277- | Lyco,  |   | Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent |
- | Review, | Var, | NA |
3273- | Lyco,  |   | Lycopene |
- | Review, | Var, | NA |
1786- | MEL,  |   | What is known about melatonin, chemotherapy and altered gene expression in breast cancer (Review) |
- | Review, | NA, | NA |
1782- | MEL,  |   | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities |
- | Review, | Var, | NA |
1780- | MEL,  |   | Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing |
- | Review, | Var, | NA |
1779- | MEL,  |   | Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review |
- | Review, | BC, | NA |
1777- | MEL,  |   | Melatonin as an antioxidant: under promises but over delivers |
- | Review, | NA, | NA |
2371- | MET,  |   | The role of pyruvate kinase M2 in anticancer therapeutic treatments |
- | Review, | Var, | NA |
2386- | MET,  |   | Mechanisms of metformin inhibiting cancer invasion and migration |
- | Review, | Var, | NA |
2244- | MF,  |   | Little strokes fell big oaks: The use of weak magnetic fields and reactive oxygen species to fight cancer |
- | Review, | Var, | NA |
2251- | MF,  | Rad,  |   | BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage |
- | in-vitro, | Lung, | A549 | - | in-vitro, | HNSCC, | UTSCC15 | - | in-vitro, | CRC, | DLD1 | - | in-vitro, | PC, | MIA PaCa-2 |
3486- | MF,  |   | Pulsed electromagnetic field potentiates etoposide-induced MCF-7 cell death |
- | in-vitro, | NA, | NA |
3457- | MF,  |   | Cellular stress response to extremely low‐frequency electromagnetic fields (ELF‐EMF): An explanation for controversial effects of ELF‐EMF on apoptosis |
- | Review, | Var, | NA |
497- | MF,  |   | In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells |
- | vitro+vivo, | NA, | MCF-7 | - | vitro+vivo, | NA, | A549 |
501- | MF,  |   | Low Intensity and Frequency Pulsed Electromagnetic Fields Selectively Impair Breast Cancer Cell Viability |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 |
529- | MF,  |   | Low-frequency magnetic field therapy for glioblastoma: Current advances, mechanisms, challenges and future perspectives |
- | Review, | GBM, | NA |
506- | MF,  | doxoR,  |   | Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells |
- | in-vitro, | OS, | LM8 |
512- | MF,  |   | Pulsed Electromagnetic Fields (PEMFs) Trigger Cell Death and Senescence in Cancer Cells |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | FF95 |
1573- | MushReishi,  |   | Ganoderma lucidum (Reishi mushroom) for cancer treatment |
- | Review, | NA, | NA |
1799- | NarG,  |   | Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics |
- | Review, | NA, | NA |
1798- | NarG,  |   | Naringenin: A potential flavonoid phytochemical for cancer therapy |
- | Review, | NA, | NA |
1811- | Oxy,  |   | Hyperbaric oxygen therapy and cancer—a review |
- | Review, | NA, | NA |
1814- | Oxy,  |   | Hyperbaric oxygen therapy for malignancy: a review |
- | Review, | Var, | NA |
1813- | Oxy,  |   | Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment |
- | Review, | Var, | NA |
2396- | PACs,  |   | PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma |
- | in-vitro, | HCC, | HCCLM3 | - | in-vitro, | HCC, | SMMC-7721 cell | - | in-vitro, | HCC, | Bel-7402 | - | in-vitro, | HCC, | HUH7 | - | in-vitro, | HCC, | HepG2 | - | in-vitro, | Nor, | L02 |
2043- | PB,  | Cisplatin,  |   | Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin |
- | in-vitro, | HNSCC, | UM-SCC-1 |
2074- | PB,  | Chemo,  |   | The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | Calu-6 | - | in-vitro, | Lung, | H1650 |
2421- | PB,  |   | Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway |
- | in-vitro, | HCC, | HCCLM3 | - | in-vivo, | NA, | NA | - | in-vitro, | HCC, | Bel-7402 | - | in-vitro, | HCC, | SMMC-7721 cell | - | in-vitro, | Nor, | L02 |
1664- | PBG,  |   | Anticancer Activity of Propolis and Its Compounds |
- | Review, | Var, | NA |
1666- | PBG,  |   | Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer |
- | Review, | Var, | NA |
1668- | PBG,  |   | Propolis: A Detailed Insight of Its Anticancer Molecular Mechanisms |
- | Review, | Var, | NA |
1672- | PBG,  |   | The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers |
- | Review, | BC, | NA |
1662- | PBG,  |   | The immunomodulatory and anticancer properties of propolis |
- | Review, | Var, | NA |
1661- | PBG,  |   | Propolis: a natural compound with potential as an adjuvant in cancer therapy - a review of signaling pathways |
- | Review, | Var, | NA |
1674- | PBG,  | SDT,  | HPT,  |   | Study on the effect of a triple cancer treatment of propolis, thermal cycling-hyperthermia, and low-intensity ultrasound on PANC-1 cells |
- | in-vitro, | PC, | PANC1 | - | in-vitro, | Nor, | H6c7 |
1676- | PBG,  |   | Use of Stingless Bee Propolis and Geopropolis against Cancer—A Literature Review of Preclinical Studies |
- | Review, | Var, | NA |
1770- | PG,  |   | Propyl gallate sensitizes human lung cancer cells to cisplatin-induced apoptosis by targeting heme oxygenase-1 for TRC8-mediated degradation |
- | in-vitro, | Lung, | NA |
2649- | PL,  |   | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
2948- | PL,  |   | The promising potential of piperlongumine as an emerging therapeutics for cancer |
- | Review, | Var, | NA |
2946- | PL,  |   | Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent |
- | Review, | Var, | NA |
2945- | PL,  |   | Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells |
- | in-vitro, | CRC, | HCT116 |
1941- | PL,  |   | Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer |
- | in-vitro, | HNSCC, | NA |
2651- | Plum,  |   | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
1493- | QC,  |   | New quercetin-coated titanate nanotubes and their radiosensitization effect on human bladder cancer |
- | NA, | Bladder, | NA |
2303- | QC,  | doxoR,  |   | Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells |
- | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
3353- | QC,  |   | Quercetin triggers cell apoptosis-associated ROS-mediated cell death and induces S and G2/M-phase cell cycle arrest in KON oral cancer cells |
- | in-vitro, | Oral, | KON | - | in-vitro, | Nor, | MRC-5 |
3347- | QC,  |   | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3368- | QC,  |   | The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update |
- | Review, | Var, | NA |
1492- | RES,  |   | Resveratrol: Biological and pharmaceutical properties as anticancer molecule |
- | Review, | Var, | NA |
1491- | RES,  |   | Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy |
1489- | RES,  |   | Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer |
- | Review, | Var, | NA |
2334- | RES,  |   | Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy |
- | Review, | Var, | NA |
2650- | RES,  |   | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
2687- | RES,  |   | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | NA, | NA | - | Review, | AD, | NA |
2441- | RES,  |   | Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions |
- | Review, | Var, | NA |
2439- | RES,  |   | By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice |
- | in-vitro, | HCC, | HCCLM3 | - | in-vitro, | Nor, | L02 | - | in-vitro, | HCC, | SMMC-7721 cell | - | in-vitro, | HCC, | Bel-7402 | - | in-vitro, | HCC, | HUH7 |
3079- | RES,  |   | Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action |
- | Review, | Var, | NA |
3063- | RES,  |   | Resveratrol: A Review of Pre-clinical Studies for Human Cancer Prevention |
- | Review, | Var, | NA |
3055- | RES,  |   | Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets |
- | Review, | Var, | NA |
3054- | RES,  |   | Resveratrol induced reactive oxygen species and endoplasmic reticulum stress-mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line |
- | in-vitro, | Melanoma, | A375 |
3083- | RES,  |   | Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
3081- | RES,  |   | Resveratrol and p53: How are they involved in CRC plasticity and apoptosis? |
- | Review, | CRC, | NA |
3001- | RosA,  |   | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
- | Review, | Var, | NA |
3002- | RosA,  |   | Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols |
- | Review, | Var, | NA |
1749- | RosA,  |   | Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer |
- | Review, | Var, | NA |
1744- | RosA,  |   | Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity |
- | Review, | Var, | NA |
1745- | RosA,  |   | Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications |
- | Review, | Var, | NA | - | Review, | AD, | NA |
1747- | RosA,  |   | Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review |
- | Review, | BC, | MDA-MB-231 | - | Review, | BC, | MDA-MB-468 |
1688- | Se,  |   | Potential Role of Selenium in the Treatment of Cancer and Viral Infections |
- | Review, | Var, | NA |
1706- | Se,  |   | Selenium in Prostate Cancer: Prevention, Progression, and Treatment |
- | Review, | Pca, | NA |
2553- | SFN,  |   | Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer |
- | Review, | Bladder, | NA |
3183- | SFN,  |   | Sulforaphane potentiates the efficacy of chemoradiotherapy in glioblastoma by selectively targeting thioredoxin reductase 1 |
- | in-vitro, | GBM, | NA |
2448- | SFN,  |   | Sulforaphane and bladder cancer: a potential novel antitumor compound |
- | Review, | Bladder, | NA |
1722- | SFN,  |   | Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems |
- | Review, | Var, | NA |
1731- | SFN,  |   | Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts |
- | Review, | Var, | NA |
1730- | SFN,  |   | Sulforaphane: An emergent anti-cancer stem cell agent |
- | Review, | Var, | NA |
1484- | SFN,  |   | Sulforaphane’s Multifaceted Potential: From Neuroprotection to Anticancer Action |
- | Review, | Var, | NA | - | Review, | AD, | NA |
1434- | SFN,  | GEM,  |   | Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity |
- | in-vitro, | CCA, | HuCCT1 | - | in-vitro, | CCA, | HuH28 | - | in-vivo, | NA, | NA |
1481- | SFN,  | docx,  |   | Combination of Low-Dose Sulforaphane and Docetaxel on Mitochondrial Function and Metabolic Reprogramming in Prostate Cancer Cell Lines |
- | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
1436- | SFN,  | PacT,  | docx,  |   | Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells |
- | in-vivo, | BC, | SUM159 |
1458- | SFN,  |   | Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma |
- | Review, | Bladder, | NA |
1474- | SFN,  |   | Sulforaphane induces p53‑deficient SW480 cell apoptosis via the ROS‑MAPK signaling pathway |
- | in-vitro, | Colon, | SW480 |
1316- | SIL,  | Chemo,  |   | Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity |
- | Analysis, | Var, | NA |
3300- | SIL,  |   | Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy |
- | Review, | Var, | NA |
3326- | SIL,  |   | Silymarin suppresses proliferation of human hepatocellular carcinoma cells under hypoxia through downregulation of the HIF-1α/VEGF pathway |
- | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | Hep3B |
2227- | SK,  |   | Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species |
- | in-vitro, | GC, | BGC-823 | - | in-vitro, | GC, | SGC-7901 | - | in-vitro, | Nor, | GES-1 |
2418- | SK,  |   | Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2 |
- | in-vitro, | HCC, | SMMC-7721 cell | - | in-vitro, | HCC, | HUH7 | - | in-vitro, | HCC, | HepG2 |
2008- | SK,  | Cisplatin,  |   | Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo |
- | in-vitro, | CRC, | HCT116 | - | in-vivo, | NA, | NA |
2184- | SK,  | Cisplatin,  |   | PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis |
- | in-vitro, | CRC, | T24 |
2182- | SK,  | Cisplatin,  |   | Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | PC9 | - | in-vivo, | NA, | NA |
2196- | SK,  |   | Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species |
- | Review, | Var, | NA |
1073- | SK,  | Chemo,  |   | Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells |
- | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | Bxpc-3 |
1626- | STF,  | dietFMD,  |   | When less may be more: calorie restriction and response to cancer therapy |
- | Review, | Var, | NA |
2129- | TQ,  | doxoR,  |   | Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells |
- | in-vitro, | BC, | MCF-7 |
2127- | TQ,  |   | Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways |
- | Review, | GBM, | NA |
2124- | TQ,  |   | Thymoquinone: an emerging natural drug with a wide range of medical applications |
- | Review, | Var, | NA |
2122- | TQ,  |   | Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer |
- | Review, | Var, | NA |
2099- | TQ,  | Cisplatin,  |   | Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo |
- | in-vitro, | Lung, | H460 | - | in-vitro, | Lung, | H146 | - | in-vivo, | NA, | NA |
2094- | TQ,  |   | Cytotoxicity of Nigella sativa Extracts Against Cancer Cells: A Review of In Vitro and In Vivo Studies |
- | Review, | Var, | NA |
2106- | TQ,  |   | Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy |
- | Review, | Var, | NA |
2090- | TQ,  |   | Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies |
- | Review, | Var, | NA |
2084- | TQ,  |   | Thymoquinone, as an anticancer molecule: from basic research to clinical investigation |
- | Review, | Var, | NA |
3422- | TQ,  |   | Thymoquinone, as a Novel Therapeutic Candidate of Cancers |
- | Review, | Var, | NA |
3425- | TQ,  |   | Advances in research on the relationship between thymoquinone and pancreatic cancer |
3427- | TQ,  |   | Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets |
3397- | TQ,  |   | Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer |
- | Review, | CRC, | NA |
3408- | TQ,  |   | Thymoquinone: A small molecule from nature with high therapeutic potential |
- | Review, | AD, | NA | - | Review, | Park, | NA |
1836- | VitC,  | VitK3,  | Chemo,  |   | Vitamins C and K3: A Powerful Redox System for Sensitizing Leukemia Lymphocytes to Everolimus and Barasertib |
- | in-vitro, | AML, | NA |
3120- | VitC,  |   | Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells |
- | in-vitro, | lymphoma, | NA |
3148- | VitC,  |   | Antioxidants in brain tumors: current therapeutic significance and future prospects |
- | Review, | Var, | NA |
3135- | VitC,  |   | The interplay between vitamin C and thyroid |
- | Review, | Thyroid, | NA |
1740- | VitD3,  |   | Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms |
- | Review, | Var, | NA |
2283- | VitK2,  |   | Vitamin K Contribution to DNA Damage—Advantage or Disadvantage? A Human Health Response |
- | Review, | Var, | NA |
2278- | VitK2,  | VitK3,  | VitC,  |   | Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect |
- | Review, | Var, | NA |
1829- | VitK2,  |   | Vitamin K: New insights related to senescence and cancer metastasis |
- | Review, | Var, | NA |
1824- | VitK2,  |   | Vitamin K and its analogs: Potential avenues for prostate cancer management |
- | Review, | Pca, | NA |
1822- | VitK2,  |   | Vitamin K: A novel cancer chemosensitizer |
- | Review, | Var, | NA |
1817- | VitK2,  |   | Research progress on the anticancer effects of vitamin K2 |
- | Review, | Var, | NA |
1818- | VitK2,  |   | New insights on vitamin K biology with relevance to cancer |
- | Review, | Var, | NA |
1827- | VitK3,  |   | A biophysical approach to menadione membrane interactions: relevance for menadione-induced mitochondria dysfunction and related deleterious/therapeutic effects |
- | Analysis, | Var, | NA |
2428- | VitK3,  |   | Vitamin K3 and K5 are inhibitors of tumor pyruvate kinase M2 |
- | Study, | Var, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1106 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid